01324-6/asset/4a54a807-9d4c-43b0-9cee-525570c8c25d/main.assets/gr2_lrg.jpg)
tirzepatide uric acid levels study Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial High Uric Acid: A Silent
Description
Why Choose IconMD for Weight Loss Treatment
Individual nutritional counseling and advice
The dose starts at 0.25 mg and increases every 4 weeks until reaching a maintenance dose, usually 2.4 mg
Some weight loss pills combine appetite suppression with other mechanisms
These treatments are most effective when paired with healthy lifestyle changes and regular monitoring
Others move to another medication that might be more affordable or have lower side effects
